Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of Dry Needling vs Botulinum Toxin type A for lower limb post-stroke spasticity (STROKE-POC)
2024-510866-18-00Phase 2Authorised
- Sponsor
- University of Antwerp
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised trial of botulinum toxin type A in poststroke spasticity (PSS) (2 arms), sponsored by University of Antwerp. Primary endpoint: Spasticity (Tonic Stretch Reflex Threshold and velocity sensitivity). Planned start Jul 2024; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
poststroke spasticity (PSS)
Beyond the preview
Go deeper on 2024-510866-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510866-18-00.